Skip to main content
. Author manuscript; available in PMC: 2024 Oct 10.
Published in final edited form as: Circulation. 2023 Sep 8;148(15):1165–1178. doi: 10.1161/CIRCULATIONAHA.123.064170

Figure 5. HFD/L-NAME treatment promotes expansion of Tet2-deficient cells in the hematopoietic stem and progenitor cells.

Figure 5.

A-F. Flow cytometric quantification of donor cell chimerism in LSK cells, MMP4 cells, MMP3 cells, MMP2 cells, long-term hematopoietic stem cells (LT-HSC), and short-term hematopoietic stem cells (ST-HSC) of the bone marrow after 12 weeks of treatment. Statistical significance was determined by 2-way ANOVA with post hoc Sidak multiple comparison test (n=4–11 per group).